Thursday 23 May 2024

South Carolina Bans Transgender Procedures, Treatments For Minors

 South Carolina Governor Henry McMaster signed a bill into law this week that bans transgender procedures and treatments for minors.

Local media reported that South Carolina became the 25th state to pass laws cracking down on the highly controversial treatments.

“I signed the Help Not Harm bill into law, which protects our state’s children from irreversible gender transition procedures and bans public funds from being used for them,” McMaster said in a statement posted to X. “I look forward to joining legislators and supporters at a ceremonial bill signing in the Upstate next week.”

The Associated Press reported that the law bans medical professionals from “performing gender-transition surgeries, prescribing puberty blockers and overseeing hormone treatments for patients under 18.”

Doctors are able to prescribe some of the treatments for minors in legitimate circumstances that the treatments were designed for, an example of which includes giving a puberty blocker to a child who has a medical condition that causes them to start puberty as young as age 4, the report said.

It also requires schools to notify parents if their child wants to use a different name or pronouns.

The new law comes amid a wave of global pushback against the far-left’s agenda of pushing transgenderism onto children.

England’s National Health Service (NHS) announced earlier this year that children will no longer be given puberty blocker prescriptions after experts concluded that there were serious safety concerns.


The NHS’ decision comes after it commissioned the National Institute for Health and Care Excellence (NICE) to review the published evidence on Gonadotrophin Releasing Hormone Analogues (GnRHa), also known as puberty blockers, which prevent the body from making sex hormones that are needed for an individual to grow and develop into a healthy adult.

“NHS England has carefully considered the evidence review conducted by NICE (2020) and has identified and reviewed any further published evidence available to date,” said an NHS England policy document released on Tuesday. “We have concluded that there is not enough evidence to support the safety or clinical effectiveness of PSH to make the treatment routinely available at this time.”

The investigation was launched after there was a massive uptick in the number of children who were being referred to the Gender Identity Development Service, a national health clinic in the U.K. The number went from 250 children in 2012 to more than 5,000 in 2022 as the transgender movement gained steam as a social trend and experts warned that it was having a contagion effect.

No comments:

Post a Comment